Detailed price information for Mama's Creations Inc (MAMA-Q) from The Globe and Mail including charting and trades.

DUBLIN and BRIDGEWATER, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced financial and operational results for the second quarter of 2025.

Amarin Corporation AMRN reported a loss of 3 cents per share for the second quarter of 2025, which was significantly narrower ...

Here is how Amarin (AMRN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

We expect investors to focus on the sales performance of Amarin Corporation’s AMRN sole marketed drug, Vascepa/Vazkepa, when it reports second-quarter 2025 results on July 30, before market open. The ...

Amarin Corp PLC (NASDAQ:AMRN) is set to release its Q2 2025 earnings on July 30, 2025. The consensus estimate for Q2 2025 revenue is $53.79 million, and the earnings are expected to come in at -$0.69 ...

Q2 2025 Management View Aaron D. Berg, President and CEO, highlighted Q2 2025 as a “pivotal quarter for Amarin, marked by ...

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ...

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ...